BINDING MOLECULES, ESPECIALLY ANTIBODIES, BINDING TO L1CAM (CD171)

The present disclosure relates to a binding molecule binding to L1, which is capable of binding to the same L1 epitope recognized by the monoclonal antibody L1-OV52.24, and/or which competes with the monoclonal antibody L1-OV52.24 for binding to L1, wherein the variable part of the light chain of L1...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LÜTTGAU, SANDRA, HAZIN, JOHN, ALTEVOGT, PETER, MOLDENHAUER, GERHARD
Format:	Patent
Sprache:	eng ; pol
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	LÜTTGAU, SANDRA HAZIN, JOHN ALTEVOGT, PETER MOLDENHAUER, GERHARD
description	The present disclosure relates to a binding molecule binding to L1, which is capable of binding to the same L1 epitope recognized by the monoclonal antibody L1-OV52.24, and/or which competes with the monoclonal antibody L1-OV52.24 for binding to L1, wherein the variable part of the light chain of L1-OV52.24 comprises the sequence according to SEQ ID No: 1 or wherein the light chain is encoded by SEQ ID No: 3, and wherein the variable part of the heavy chain of L1-OV52.24 comprises the sequence according to SEQ ID No: 2 or wherein the heavy chain is encoded by SEQ ID No: 4, nucleic acids encoding the binding molecules, uses thereof and pharmaceutical compositions comprising the binding molecules.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL3200822TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL3200822TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL3200822TT33</originalsourceid><addsrcrecordid>eNrjZHBy8vRz8fRzV_D193F1DvVxDdZRcA0OcHX2dPTxiVRw9AvxdPJ38QQJw1SG-Cv4GDo7-ipoOLsYmhtq8jCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSS-AAfYyMDAwsjo5AQY2Ni1AAApuoqmw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BINDING MOLECULES, ESPECIALLY ANTIBODIES, BINDING TO L1CAM (CD171)</title><source>esp@cenet</source><creator>LÜTTGAU, SANDRA ; HAZIN, JOHN ; ALTEVOGT, PETER ; MOLDENHAUER, GERHARD</creator><creatorcontrib>LÜTTGAU, SANDRA ; HAZIN, JOHN ; ALTEVOGT, PETER ; MOLDENHAUER, GERHARD</creatorcontrib><description>The present disclosure relates to a binding molecule binding to L1, which is capable of binding to the same L1 epitope recognized by the monoclonal antibody L1-OV52.24, and/or which competes with the monoclonal antibody L1-OV52.24 for binding to L1, wherein the variable part of the light chain of L1-OV52.24 comprises the sequence according to SEQ ID No: 1 or wherein the light chain is encoded by SEQ ID No: 3, and wherein the variable part of the heavy chain of L1-OV52.24 comprises the sequence according to SEQ ID No: 2 or wherein the heavy chain is encoded by SEQ ID No: 4, nucleic acids encoding the binding molecules, uses thereof and pharmaceutical compositions comprising the binding molecules.</description><language>eng ; pol</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211108&DB=EPODOC&CC=PL&NR=3200822T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211108&DB=EPODOC&CC=PL&NR=3200822T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LÜTTGAU, SANDRA</creatorcontrib><creatorcontrib>HAZIN, JOHN</creatorcontrib><creatorcontrib>ALTEVOGT, PETER</creatorcontrib><creatorcontrib>MOLDENHAUER, GERHARD</creatorcontrib><title>BINDING MOLECULES, ESPECIALLY ANTIBODIES, BINDING TO L1CAM (CD171)</title><description>The present disclosure relates to a binding molecule binding to L1, which is capable of binding to the same L1 epitope recognized by the monoclonal antibody L1-OV52.24, and/or which competes with the monoclonal antibody L1-OV52.24 for binding to L1, wherein the variable part of the light chain of L1-OV52.24 comprises the sequence according to SEQ ID No: 1 or wherein the light chain is encoded by SEQ ID No: 3, and wherein the variable part of the heavy chain of L1-OV52.24 comprises the sequence according to SEQ ID No: 2 or wherein the heavy chain is encoded by SEQ ID No: 4, nucleic acids encoding the binding molecules, uses thereof and pharmaceutical compositions comprising the binding molecules.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHBy8vRz8fRzV_D193F1DvVxDdZRcA0OcHX2dPTxiVRw9AvxdPJ38QQJw1SG-Cv4GDo7-ipoOLsYmhtq8jCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSS-AAfYyMDAwsjo5AQY2Ni1AAApuoqmw</recordid><startdate>20211108</startdate><enddate>20211108</enddate><creator>LÜTTGAU, SANDRA</creator><creator>HAZIN, JOHN</creator><creator>ALTEVOGT, PETER</creator><creator>MOLDENHAUER, GERHARD</creator><scope>EVB</scope></search><sort><creationdate>20211108</creationdate><title>BINDING MOLECULES, ESPECIALLY ANTIBODIES, BINDING TO L1CAM (CD171)</title><author>LÜTTGAU, SANDRA ; HAZIN, JOHN ; ALTEVOGT, PETER ; MOLDENHAUER, GERHARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL3200822TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LÜTTGAU, SANDRA</creatorcontrib><creatorcontrib>HAZIN, JOHN</creatorcontrib><creatorcontrib>ALTEVOGT, PETER</creatorcontrib><creatorcontrib>MOLDENHAUER, GERHARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LÜTTGAU, SANDRA</au><au>HAZIN, JOHN</au><au>ALTEVOGT, PETER</au><au>MOLDENHAUER, GERHARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BINDING MOLECULES, ESPECIALLY ANTIBODIES, BINDING TO L1CAM (CD171)</title><date>2021-11-08</date><risdate>2021</risdate><abstract>The present disclosure relates to a binding molecule binding to L1, which is capable of binding to the same L1 epitope recognized by the monoclonal antibody L1-OV52.24, and/or which competes with the monoclonal antibody L1-OV52.24 for binding to L1, wherein the variable part of the light chain of L1-OV52.24 comprises the sequence according to SEQ ID No: 1 or wherein the light chain is encoded by SEQ ID No: 3, and wherein the variable part of the heavy chain of L1-OV52.24 comprises the sequence according to SEQ ID No: 2 or wherein the heavy chain is encoded by SEQ ID No: 4, nucleic acids encoding the binding molecules, uses thereof and pharmaceutical compositions comprising the binding molecules.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; pol
recordid	cdi_epo_espacenet_PL3200822TT3
source	esp@cenet
subjects	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	BINDING MOLECULES, ESPECIALLY ANTIBODIES, BINDING TO L1CAM (CD171)
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T23%3A44%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=L%C3%9CTTGAU,%20SANDRA&rft.date=2021-11-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL3200822TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true